Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)

Also known as: Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL) / Refractory or Relapsed B-cell Non-Hodgkin Lymphoma / Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma / Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma / Relapsed or Refractory B Cell Non-Hodgkin Lymphoma / Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB17362Obecabtagene autoleucel1Recruiting1
DB12887Tazemetostat1Completed1
DB06769Bendamustine1 / 2Unknown Status1
DB00531Cyclophosphamide1 / 2Unknown Status1
DB12218Capivasertib2Active Not Recruiting1
DB12887Tazemetostat2Completed1
DB06334Tucidinostat2Recruiting1
DB00928AzacitidineNot AvailableEnrolling by Invitation1
DB00531CyclophosphamideNot AvailableEnrolling by Invitation1
DB01073FludarabineNot AvailableEnrolling by Invitation1
DB00480LenalidomideNot AvailableEnrolling by Invitation1
DB08935ObinutuzumabNot AvailableEnrolling by Invitation1
DB15035ZanubrutinibNot AvailableEnrolling by Invitation1